Intellia Therapeutics, Inc. - 10-Q Filing
Intellia Therapeutics filed its Q1 2026 10-Q with the SEC on April 28, 2026. The filing includes financial data for the quarter ended March 31, 2026, and covers operating segments including Nex-Z, Lonvo-Z, and other research and development activities.
Tickers: $NTLA